![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | RGD:10759 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IDH3G mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:10759 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of IDH3G mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:10759 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IDH3G mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:10759 | 6480464 | Ethinyl Estradiol results in increased expression of IDH3G mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:10759 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IDH3G mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of IDH3G mRNA | CTD | PMID:26496021 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10759 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IDH3G mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10759 | 6480464 | Tetrachlorodibenzodioxin affects the expression of IDH3G mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of IDH3G mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of IDH3G mRNA | CTD | PMID:21215274 | 2,4,6-trinitrotoluene | affects expression | EXP | | 6480464 | Trinitrotoluene affects the expression of IDH3G mRNA | CTD | PMID:21346803 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:731354 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of IDH3G protein | CTD | PMID:31945527 | aflatoxin B1 | decreases expression | ISO | RGD:10759 | 6480464 | Aflatoxin B1 results in decreased expression of IDH3G mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | increases expression | ISO | RGD:731354 | 6480464 | Tretinoin results in increased expression of IDH3G mRNA | CTD | PMID:33167477 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of IDH3G mRNA | CTD | PMID:16483693 | aristolochic acid A | decreases expression | ISO | RGD:731354 | 6480464 | aristolochic acid I results in decreased expression of IDH3G mRNA | CTD | PMID:33212167 | benzo[a]pyrene | affects methylation | ISO | RGD:731354 | 6480464 | Benzo(a)pyrene affects the methylation of IDH3G promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | RGD:731354 | 6480464 | Benzo(a)pyrene results in increased methylation of IDH3G 5' UTR, Benzo(a)pyrene results in increased methylation of IDH3G exon | CTD | PMID:27901495 | benzo[e]pyrene | increases methylation | ISO | RGD:731354 | 6480464 | benzo(e)pyrene results in increased methylation of IDH3G polyA tail | CTD | PMID:30157460 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of IDH3G mRNA | CTD | PMID:26496021 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of IDH3G mRNA | CTD | PMID:25181051, PMID:34947998 | Bisphenol B | increases expression | ISO | RGD:731354 | 6480464 | bisphenol B results in increased expression of IDH3G protein | CTD | PMID:34186270 | bisphenol F | increases expression | ISO | RGD:731354 | 6480464 | bisphenol F results in increased expression of IDH3G protein | CTD | PMID:34186270 | cannabidiol | multiple interactions | ISO | RGD:731354 | 6480464 | [Cannabidiol co-treated with moringin] results in increased expression of IDH3G mRNA | CTD | PMID:30096889 | carbon nanotube | increases expression | ISO | RGD:10759 | 6480464 | Nanotubes, Carbon results in increased expression of IDH3G mRNA | CTD | PMID:25620056 | diazinon | increases methylation | ISO | RGD:731354 | 6480464 | Diazinon results in increased methylation of IDH3G gene | CTD | PMID:22964155 | dibutyl phthalate | decreases expression | ISO | RGD:10759 | 6480464 | Dibutyl Phthalate results in decreased expression of IDH3G mRNA | CTD | PMID:17361019 | doxorubicin | decreases expression | ISO | RGD:10759 | 6480464 | Doxorubicin results in decreased expression of IDH3G mRNA | CTD | PMID:26873546 | elemental selenium | multiple interactions | ISO | RGD:731354 | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of IDH3G mRNA | CTD | PMID:19244175 | elemental selenium | increases expression | ISO | RGD:731354 | 6480464 | Selenium results in increased expression of IDH3G mRNA | CTD | PMID:19244175 | flavonoids | decreases expression | EXP | | 6480464 | Flavonoids results in decreased expression of IDH3G mRNA | CTD | PMID:18035473 | folic acid | multiple interactions | ISO | RGD:10759 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IDH3G mRNA | CTD | PMID:22206623 | folpet | increases expression | ISO | RGD:10759 | 6480464 | folpet results in increased expression of IDH3G mRNA | CTD | PMID:31558096 | glyphosate | decreases expression | EXP | | 6480464 | glyphosate results in decreased expression of IDH3G mRNA | CTD | PMID:26302742 | gold atom | multiple interactions | ISO | RGD:731354 | 6480464 | [Polyethyleneimine binds to Gold] which results in increased expression of IDH3G mRNA | CTD | PMID:28433809 | gold(0) | multiple interactions | ISO | RGD:731354 | 6480464 | [Polyethyleneimine binds to Gold] which results in increased expression of IDH3G mRNA | CTD | PMID:28433809 | hydralazine | multiple interactions | ISO | RGD:731354 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of IDH3G mRNA | CTD | PMID:17183730 | indometacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of IDH3G mRNA | CTD | PMID:36868495 | ivermectin | decreases expression | ISO | RGD:731354 | 6480464 | Ivermectin results in decreased expression of IDH3G protein | CTD | PMID:32959892 | lamivudine | multiple interactions | ISO | RGD:10759 | 6480464 | [Zidovudine co-treated with Lamivudine] results in decreased expression of IDH3G mRNA | CTD | PMID:18313992 | manganese atom | affects binding | ISO | RGD:731354 | 6480464 | Manganese binds to IDH3G protein | CTD | PMID:16737955 | manganese atom | multiple interactions | ISO | RGD:10759 | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in decreased expression of IDH3G mRNA | CTD | PMID:35690225 | manganese(0) | affects binding | ISO | RGD:731354 | 6480464 | Manganese binds to IDH3G protein | CTD | PMID:16737955 | manganese(0) | multiple interactions | ISO | RGD:10759 | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in decreased expression of IDH3G mRNA | CTD | PMID:35690225 | manganese(II) chloride | multiple interactions | ISO | RGD:10759 | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in decreased expression of IDH3G mRNA | CTD | PMID:35690225 | methapyrilene | increases methylation | ISO | RGD:731354 | 6480464 | Methapyrilene results in increased methylation of IDH3G polyA tail | CTD | PMID:30157460 | methylazoxymethanol | increases expression | ISO | RGD:10759 | 6480464 | methylazoxymethanol results in increased expression of IDH3G mRNA | CTD | PMID:17107856 | ochratoxin A | decreases expression | ISO | RGD:731354 | 6480464 | ochratoxin A results in decreased expression of IDH3G mRNA | CTD | PMID:19287073 | oxybenzone | increases expression | EXP | | 6480464 | oxybenzone results in increased expression of IDH3G mRNA | CTD | PMID:30316929 | ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of IDH3G mRNA | CTD | PMID:25838073 | paracetamol | affects expression | ISO | RGD:10759 | 6480464 | Acetaminophen affects the expression of IDH3G mRNA | CTD | PMID:17562736 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:10759 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IDH3G mRNA | CTD | PMID:36331819 | phenethyl caffeate | multiple interactions | ISO | RGD:10759 | 6480464 | [caffeic acid phenethyl ester co-treated with Dietary Fats] results in increased expression of IDH3G mRNA, NR1H4 protein affects the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in increased expression of IDH3G mRNA] | CTD | PMID:28223344 | phenobarbital | affects expression | ISO | RGD:731354 | 6480464 | Phenobarbital affects the expression of IDH3G mRNA | CTD | PMID:19159669 | phlorizin | decreases expression | ISO | RGD:10759 | 6480464 | Phlorhizin results in decreased expression of IDH3G mRNA | CTD | PMID:22538082 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of IDH3G mRNA | CTD | PMID:19162173 | potassium chromate | decreases expression | ISO | RGD:731354 | 6480464 | potassium chromate(VI) results in decreased expression of IDH3G mRNA | CTD | PMID:22714537 | selenium atom | multiple interactions | ISO | RGD:731354 | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of IDH3G mRNA | CTD | PMID:19244175 | selenium atom | increases expression | ISO | RGD:731354 | 6480464 | Selenium results in increased expression of IDH3G mRNA | CTD | PMID:19244175 | sunitinib | decreases expression | ISO | RGD:731354 | 6480464 | Sunitinib results in decreased expression of IDH3G mRNA | CTD | PMID:31533062 | triptonide | decreases expression | ISO | RGD:10759 | 6480464 | triptonide results in decreased expression of IDH3G mRNA | CTD | PMID:33045310 | troglitazone | decreases expression | ISO | RGD:10759 | 6480464 | troglitazone results in decreased expression of IDH3G mRNA | CTD | PMID:12732648 | valproic acid | decreases expression | ISO | RGD:731354 | 6480464 | Valproic Acid results in decreased expression of IDH3G mRNA | CTD | PMID:29154799 | valproic acid | multiple interactions | ISO | RGD:731354 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of IDH3G mRNA | CTD | PMID:17183730 | vitamin E | multiple interactions | ISO | RGD:731354 | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of IDH3G mRNA | CTD | PMID:19244175 | vitamin E | increases expression | ISO | RGD:731354 | 6480464 | Vitamin E results in increased expression of IDH3G mRNA | CTD | PMID:19244175 | zidovudine | multiple interactions | ISO | RGD:10759 | 6480464 | [Zidovudine co-treated with Lamivudine] results in decreased expression of IDH3G mRNA | CTD | PMID:18313992 | |